Stay informed of the latest pharmaceutical sales news to help you in your search for pharmaceutical sales jobs. Jobs in pharmaceutical sales are greatly affected by external factors, so staying abreast of the latest pharmaceutical sales news is essential for those pursuing jobs in pharmaceutical sales, marketing and management.
May 09, 2012 11:48 AM
A proposal by the Food and Drug Administration to classify certain prescription drugs in a new category got a boost from the insurance industry as the agency recenlty sought comment on the plan from the public and stakeholders.Following the open comment period, health insurers told the agency that t... (read more)
|
May 07, 2012 12:19 PM
It appears as if an executive order by President Barack Obama has helped boost pharmaceutical sales and stave off increasing shortages of a number of lifesaving drugs.The Food and Drug Administration (FDA) said that the number of new drug shortages has fallen by more than half so far this year after... (read more)
|
May 04, 2012 12:28 PM
In an effort to expand pharmaceutical sales and sustain more biotechnology jobs, the National Institutes of Health (NIH) has launched a new initiative aimed at developing new drugs from experimental compounds currently not in use.The Discovering New Therapeutic Uses for Existing Molecule is a collab... (read more)
|
May 01, 2012 12:58 PM
In charge of approving new drugs for pharmaceutical sales, the Food and Drugs Administration (FDA) is now debating a move to make certain medications available without a prescription.The federal agency said the move would help cut down the growing costs of healthcare. Critics say the change would me... (read more)
|
Apr 30, 2012 02:24 PM
As many pharmaceutical sales companies are trying to cope with potential lost profits as the Food and Drug Administration (FDA) approves more generics for commercialization, Merck is celebrating its victory against Mylan in two patent infringement lawsuits.A federal district judge in New Jersey has ... (read more)
|
Apr 25, 2012 12:45 PM
A new report by the Manhattan Institute for Policy Research has found that the high cost of clinical trials is a driving force in delaying the development of innovative new drugs.The study, "The True Cost of Lengthy Clinical Drug Trials," found that outdated Food and Drug Administration (F... (read more)
|
Apr 24, 2012 11:56 AM
The head of the Association of Clinical Research Organizations (ACRO) recently testified before the Food and Drug Administration (FDA) on proposed changes to the Prescription Drug User Fee Act (PDUFA).Dr. Doug Peddicord, ARCO executive director, provided the federal agency with a number of suggestio... (read more)
|
Apr 23, 2012 12:42 PM
Democratic lawmakers have introduced bills on Capitol Hill that could change the way generic pharmaceutical sales companies do business in the future.Senator Patrick J. Leahy, a sponsor of one of the bills, said the legislation would permit generic drug companies to update warning information about ... (read more)
|
Apr 18, 2012 01:24 PM
Generic pharmaceuticals sales company Caraco has scored a win after the country's highest court ruled it could sue Novo Nordisk over its patent for the Type 2 diabetes drug Prandin.Overturning an earlier ruling by a U.S. appeals court, the Supreme Court determined that Novo's patent for the ... (read more)
|
Apr 13, 2012 12:10 PM
As the pharmaceutical sales industry faces strong competition from low-cost generic names hitting the market and government spending cutbacks, the head of Sanofi recently touted Massachusetts for its "strong quality of life," where the life sciences sector can thrive and generate jobs.Spea... (read more)
|
Apr 11, 2012 12:23 PM
The battle over generic pharmaceutical sales is heating up after the Food and Drug Administration (FDA) denied a petition from ViroPharma to prevent copycat versions of its antibiotic Vancocin from hitting the market.Federal officials not only denied ViroPharma's request, but dealt the company a... (read more)
|
Apr 06, 2012 12:50 PM
As the battle over generic drug rights heats up in the pharmaceutical sales industry, Mylan has filed a suit against the Food and Drug Administration (FDA) after it granted Teva exclusive rights to market a copycat version of the sleep disorder drug Provigil.Teva announced that the FDA decided that ... (read more)
|
Apr 04, 2012 12:05 PM
Pharmaceutical sales representatives know how important it is to protect the integrity of their companies' products. Now, federal health officials are warning cancer patients that a new counterfeit batch of Avastin has hit the U.S. market.The Food and Drug Administration (FDA) said it is investi... (read more)
|
Apr 04, 2012 12:04 PM
Opposition to the proposed merger between pharmacy benefits managers (PBMs) Express Scripts Incorporated (ESI) and Medco Health Solutions is building after federal officials closed their antitrust investigation into the upcoming deal.Former Congresswoman Eva M. Clayton, who now heads the Prese... (read more)
|
Mar 30, 2012 10:43 AM
A state Senate committee in North Carolina is looking at a bill that would block lawsuits against pharmaceutical sales companies over products that were approved for commercialization by the Food and Drug Administration (FDA).Under the proposal now being considered by the Pharmaceutical Liability Su... (read more)
|
Mar 23, 2012 12:55 PM
A new report has found that the generic pharmaceutical sales and manufacturing industry is expected to see continued short-term growth, buoyed by healthcare reform and an increase of patients who will have insurance coverage for prescription drugs.According to the report by the industry research fir... (read more)
|
Mar 21, 2012 12:54 PM
Professionals with jobs in pharmaceutical sales understand the importance of branding when it comes to marketing their companies' products. Now, Abbott Laboratories has filed an infringement lawsuit against Watson Pharmaceuticals in an effort to block it from selling a generic version of the cho... (read more)
|
Mar 13, 2012 11:17 AM
As Congress debates the renewal of the Prescription Drug User Fee Act (PDUFA), a number of industry leaders are calling on lawmakers to include legislation to promote development and pharmaceutical sales of more antibiotics.The Infectious Diseases Society of American (IDSA) recently submitted ... (read more)
|
Mar 14, 2012 11:07 AM
A panel of experts has recommended that the Food and Drug Administration (FDA) allow the testing of an experimental class of arthritis pain treatments, despite concerns that the drugs may be linked to joint failure and bone decay.By an unanimous vote, the FDA's 21-member advisory panel sai... (read more)
|
Mar 14, 2012 10:16 AM
In a move that could change the future of pharmaceutical sales, the Food and Drug Administration is considering a proposal that could make certain popular prescription medicines available over the counter (OTC).The FDA said the goal is to make sure that people get the drugs they need to treat some o... (read more)
|